SPIRIT2 trial on dasatinib for AML - safety and side effect management
Guidance on how to prevent infections in patients with CLL
T-SPOT assay for tuberculosis and cytomegalovirus - benefits, results and next steps
Phase II trial of sorafenib plus standard therapy in newly diagnosed acute myeloid leukaemia
How do novel agents affect allogeneic transplantation in CLL?